| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | ambrisentan | FAERS: 14 | US FAERS | |
| 2 | treprostinil | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | 4-Aminopyridine | FAERS: 5 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 4 | Bosentan | FAERS: 5 | US FAERS | |
| 5 | Fingolimod Hydrochloride | FAERS: 4 | US FAERS | |
| 6 | macitentan | FAERS: 4 | US FAERS | |
| 7 | Epoprostenol | FAERS: 2 | US FAERS | |
| 8 | riociguat | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Albuterol | FAERS: 1 | US FAERS | |
| 10 | LCZ 696 | FAERS: 1 | US FAERS | |
| 11 | Norgestrel | FAERS: 1 | US FAERS | |
| 12 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 13 | Tadalafil | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | pirfenidone | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | selexipag | FAERS: 1 | US FAERS | |
| 16 | sofosbuvir-velpatasvir drug combination | FAERS: 1 | US FAERS | |
| 17 | treprostinil | Canada Vigilance: 2 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.